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Background: Despite current advances in diagnostics and medicines, the incidence of lung
cancer is increasing and effective treatment is very challenging. Traditional herbal formulae
as well as many herbal plant extracts have been recognized as attractive sources for novel
multi-targeted therapy of cancer with minimal side effects.
Methods: The ethanol extract of Kilkyung-baeksan (EE-KKBS) and its component herbs were
tested for their ability to inhibit cancer growth in several lung cancer cell lines. The effects
of EE-KKBS and ethanol extract of Croton tiglium Linné seed (EE-CT) on cell cycle progression
were measured by ﬂow cytometric analysis using propidium iodide staining. Western blot
analyses were performed to measure the expression proﬁles of proteins regulating cell cycle
checkpoints.
Results: EE-KKBS inhibited the growth of lung cancer cells after 24–72hours treatment. Lung
cancer cells treated with either EE-KKBS or EE-CT showed strong G0/G1 cell cycle arrest. The
expressions of p21 and p27, two key regulators of G1 cell cycle checkpoint, were signiﬁcantly
upregulated upon treatment with EE-KKBS and EE-CT.
Conclusion: EE-KKBS exerted its cytostatic activity through regulatingG1 cell cycle checkpoint
in lung cancer cells, and this activity ismainlymediatedbyoneof its componentherbs, seedsof Croton tiglium. Collectively, our data suggest that EE-KKBS could be a novel candidate for
adjuvant therapy for lung cancer.
© 2015 Korea Institute of Oriental Medicine. Published by Elsevier. This is an open access
carcinoma. Non small cell lung cancer (NSCLC) is the most1. IntroductionLung cancer is the most frequent malignancy and also one of
the leading causes of cancer-relatedmortality in bothmenand
women worldwide.1 Based on the World Health Organization,
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there are four major types of lung cancer; squamous cell car-
cinoma, small-cell carcinoma, adenocarcinoma, and large cell
2e Research Division, Korea Institute of Oriental Medicine, 1672
frequent type in all cases, accounting for 75–80%of lung cancer
cases. Although common treatment for lung cancer include
surgery, radiotherapy, and chemotherapy, the 5-year survival
vier. This is an open access article under the CC BY-NC-ND license
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ate among lung patients remains very low3 partly due to the
ate diagnosis and no optimal treatment option for lung can-
er.
Using medicinal plants to ﬁght against various human dis-
ases including cancer have been widely practiced all around
he world, especially in China, India, as well as in Korea.
ompared with the conventional cancer chemotherapy, the
ixture of phytochemicals in the medicinal plants may have
ynergistic effect that targets several pathways responsible
or cancer pathogenesis, thus increasing the therapeutic efﬁ-
acy along with reducing side effects.4,5 The main issues of
erbal extract for any therapeutic usage are hardship in qual-
ty control of plant materials, herbal standardization, and lack
f scientiﬁc study supports its therapeutic value.
Kilkyung-Baeksan (KKBS) is three-herb containing tradi-
ional Korean Medicine (KM) formula: the root of Platycodon
randiﬂorumA.DeCandolle (PG), the seedofCroton tiglium Linné
CT), and the bulb of Fritillaria thunbergii Miquel (FT). This for-
ula ﬁrst appeared in an old Chinese Medical book written in
arly 3rd century, Kumkye-yorak (Jin Gui Yau Lue in Chinese;
edical Treasures of the Golden Chamber) and repeatedly
entioned in various books on KM including Dongeui-bogam,
well-known Encyclopedia of Korean Medicine. It has been
idely used for various lung diseases such as coughs, short
reath, pneumonia, and lung cancer-like symptoms. Although
here is no scientiﬁc study in regard to the pharmacologi-
al or biological effect of KKBS, one of its constituents, the
oot of Platycodon grandiﬂorum A.De Candolle, is known to
ave properties such as inducing apoptosis in various cancer
ell lines including prostate6 and colon cancer,7 suppressing
GF1-induced epithelial-mesenchymal transition,8 and hep-
toprotective activity.9
In this study, we evaluated the effect of Kilkyung-Baeksan
KKBS) on various human lung cancer cell lines and found that
thanol extract of KKBS (EE-KKBS) and Croton tiglium seed (EE-
T), one of its constituents, possessed potent cell cycle arrest
ctivities without high cytotoxicity which might confer on its
nticancer ability.
. Methods
.1. Herbal formula and plant materials
KBS is composed of three kinds of herbs. The names, parts,
nd proportions of each herb comprising KKBS are described
n Table 1. These medicinal herbs were purchased from
wangmyungdang Medicinal Herbs Co. (Ulsan, Republic of
orea) and voucher specimens for all herbs were deposited
nd coded (details are summarized in Table 1) at the Can-
er Research Team, KM-Convergence Research Division, Korea
Table 1 – Herbal constituents of KKBS
Voucher code Latin name
10032 Platycodonis radix Platy
10018 Crotonis semen Croto
10025 Fritillariae bulbus Fritil
KKBS, Kilkyung-Baeksan.179
Institute of Oriental Medicine, Daejeon, Republic of Korea. The
identiﬁcation of each medicinal herb was conﬁrmed by Dr. Go
Ya Choi, K-Herb Research Center, Korea Institute of Oriental
Medicine.
2.2. Preparation of ethanol extract of KKBS and its
component herbs
The ethanol extracts of KKBS and each component were pre-
pared as follows. The dried and ground plant materials were
mixed accordingly and were extracted with 70% ethanol by
sonication. After extraction, each extract was ﬁltered using
3MM paper and freeze-dried to get a powered form. Each pow-
dered herbal extract was ﬁrst dissolved in dimethyl sulfoxide
(DMSO) at 20mg/mL concentration, then diluted to 2mg/mL
in phosphate-buffered saline (DMSO concentration in stock
solution is 10%) and stored at −20 ◦C for further use.
2.3. Cell culture
All cell lines used in this study were purchased from American
Type Culture Collection (ATCC; Manassas, VA, USA). Human
lung cancer cell lines including A549, NCI-H460, NCI-H23, and
NCI-H226 were cultured in RPMI 1640 media, and normal lung
ﬁbroblast cell lines were cultured in Dulbecco’s modiﬁed eagle
medium (DMEM; Life Technologies, Grand Islands, NY, USA)
supplemented with 10% fetal bovine serum (FBS; Invitrogen,
Carlsbad, CA, USA), 100U/mL penicillin, and 100g/mL strep-
tomycin (Invitrogen), and maintained at 37 ◦C in a humidiﬁed
incubator with 5% CO2 atmosphere.
2.4. Cell proliferation assay
Cells in the logarithmic growth phase were seeded into
ﬂat-bottom 96-well plates at a density of 5×103 cells
per well and allowed to attach overnight prior to drug
treatment. Cells were exposed to 100 ug/mL of KKBS and
herbal extracts for 48hours, and cell proliferative activity
was measured using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium
(MTS) assay kit (Promega, Madison, WI, USA). The max-
imum concentration of vehicle (DMSO) in culture media
was adjusted to 1% (v/v) and this concentration was used
as control treatment. The relative proliferative index was
calculated as percentage (%) of experimental optical density
(OD) value divided by control (vehicle) OD value.
2.5. Cell growth and viabilityCells were seeded into six well plates at a density of 1×105
cells/well overnight and treated with 100microgram/mL
of herbal extracts. After 16hours, 24hours, 48hours, and
Scientiﬁc name Ratio (weight)
codon grandiﬂorum A. De Candolle 3
n tiglium Linné 1
laria thunbergii Miquel 3
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72hours, all cells including detached cells were collected
and the numbers of total (viable and dead) and dead cells
were determined using the ADAM-MC automatic cell counter
(Nanoentek, Seoul, Korea) as described previously.10 The num-
ber of total cells and the cell viability were automatically
calculated.
2.6. Cell cycle analysis
The ratio of cells in each phase of cell cycle was determined
by cell’s DNA content using propidium iodidie (PI) staining
followed by ﬂow cytometric analysis. Cells were plated onto
six-well plates at the density of 2×105 cells/well were treated
with indicated concentrations of KKBS and herbal extracts
for indicated times as described in the ﬁgure legends. Cells
were trypsinized, washed twice with PBS, and ﬁxed with
70% ice-cold ethanol at −20 ◦C overnight. Fixed cells were
washed with cold PBS and resuspended with PI staining solu-
tion containing 50microgram/mL PI (Sigma-Aldrich, St. Louis,
MO, USA), 100microgram/mL RNase A, and 0.5% Triton X-100
(Sigma-Aldrich) and incubated in the dark for 30minutes and
analyzed using FACSCalibur (BD Biosciences, Franklin Lakes,
NJ, USA). Cell cycle proﬁles were analyzed using ModFit LT 3.2
software (BD Biosciences).
2.7. Western blot analysis
Changes in intracellular protein levels by EE-KKBSand its com-
ponentherbal extract treatmentsweredeterminedbyWestern
blot analysis. A549 human lung cancer cells were plated at
1×106 cells/dish in 60-mm culture dishes 16–24hours before
drug treatment. Cells were treated with 50microgram/mL and
100microgram/mL of each herbal extract for 24hours. The
total protein was extracted with ice-cold RIPA buffer (Thermo
Scientiﬁc, Rockford, IL, USA) containing Complete protease
inhibitor cocktail (Roche) and phosphatase inhibitor cocktail
2 and 3 (Sigma-Aldrich), and the protein concentration was
quantiﬁed by the BCA colorimetric method (Thermo Scien-
tiﬁc). Twenty-ﬁve micrograms of proteins were separated on
sodium dodecyl sulfate-polyacrylamide (SDS-PAGE) gels and
transferred to nitrocellulose membranes. The protein-blotted
membrane was blocked with a 5% (w/v) skim milk solution
in Tris-buffered saline (TBS) containing 0.1% Tween 20 for 1
hour at room temperature (RT) and then probed with primary
antibodies at 4 ◦C overnight. The primary antibodies were
Table 2 – Cytotoxic activity of EE-KKBS and component herbs o
Cell line
Control EE-KKBS
A549 100.05 ± 3.74 92.93 ± 3.96
NCI-H23 100.07 ± 5.13 89.21 ± 5.19
NCI-H226 100.22 ± 2.91 94.09 ± 2.02
NCI-H460 100.00 ± 0.99 73.66 ± 8.77
Cell viabilities after 48hours drug treatment compared with control (0.5%
done in triplicate/out of 3 independent experiments).
DMSO, dimethyl sulfoxide; EE-CT, ethanol extract of Croton tiglium Linné s
root; EE-FT, ethanol extract of Fritillaria thunbergii Miquel bulb; EE-KKBS, etIntegr Med Res ( 2 0 1 5 ) 178–184
captured with species-speciﬁc secondary antibodies con-
jugated with horseradish peroxidase for 1 hour at RT.
Membranes were visualized using SuperSignal West Femto Kit
(Thermo Scientiﬁc) and the chemiluminescence was detected
by FUSION SL (Vilber Lourmat, Marne La Vallée, France). Pri-
mary antibodies against p53, p21, and p27 were purchased
from Cell signaling Technology (Danvers, MA, USA) and anti-
Actin antibody was obtained from Santa Cruz Technology
(Dallas, TX, USA).
3. Results
3.1. Effect of ethanol extract of KKBS on the viability
of lung cancer cell lines
To investigate the effect of ethanol extract of KKBS (EE-KKBS)
on lung cancer cells, four different human lung cancer cell
lines were selected and treated with 100microgram/mL EE-
KKBS for 48hours and the cell proliferative activities were
measured by MTS assay. As shown in Table 2, the proliferation
indices of cells treated with KKBS were not signiﬁcantly differ-
ent from those of control cells, ranging 73.66–94.09% of vehicle
control. Since herbal formula contain many ingredients from
individual herbs that might exert synergistic or antagonistic
effects, each medicinal herb composing KKBS was investi-
gated for its anti or proproliferative activity. It was shown that
any ethanol extract of the herbal constituent in KKBS exerted
neither cytotoxic effect nor proliferative effect on any lung
cancer cell line tested (Table 2).
Next, effect of EE-KKBS on the growth and viability of lung
cancer cells were assessed using NCI-H460 human lung can-
cer cell line. Cells plated and treated with 100microgram/mL
EE-KKBS were harvested at 16hours, 24hours, 48hours, and
72hours and total cell numbers andviabilitieswere calculated.
The EE-KKBS exerted potent growth inhibitory effect starting
at 24hourspost treatment inNCI-H460human lung cancer cell
line (Fig. 1A), however, there were little change in the viability
of lung cancer cells treated with EE-KKBS even after 72hours
(Fig. 1B).
3.2. Effect of EE-KKBS on cell cycle distribution of lung
cancer cell lines
Even though EE-KKBS did not show cytotoxicity on various
lung cancer cell lines, it might exert cytostatic effect such
n lung cancer cell lines
Cell viability (100 microgram/mL, 48 h, %)
EE-CT EE-PG EE-FT
93.85 ± 1.56 98.13 ± 4.57 97.13 ± 3.18
87.42 ± 8.17 99.32 ± 1.50 95.14 ± 5.18
100.31 ± 5.57 104.87 ± 7.71 112.73 ± 3.26
83.73 ± 3.34 104.75 ± 8.43 96.67 ± 2.44
DMSO) are expressed as mean ± SD (1 representative experiment
eed; EE-PG, ethanol extract of Platycodon grandiﬂorum A.De Candolle
hanol extract of Kilkyung-baeksan; SD, standard deviation.
J. Kim et al/KKBS regulates G1 cell cycle checkpoint in lung cancer 181
Table 3 – Cell cycle distribution for NCI-H460 human lung cancer cells treated with EE-KKBS
% Cells on each cell cycle phase
G0/G1 G2/M S
Control 16 h 58.31 ± 2.48 11.36 ± 0.50 30.33 ± 1.98
24 h 55.25 ± 3.72 15.77 ± 3.28 28.98 ± 0.45
48 h 69.43 ± 7.20 7.08 ± 1.26 23.49 ± 5.94
EE-KKBS 16 h 83.99 ± 1.29 5.81 ± 1.19 10.21 ± 0.10
24 h 82.63 ± 0.59 6.54 ± 1.37 10.83 ± 0.79
48 h 91.24 ± 0.90 3.24 ± 0.07 5.52 ± 0.83
endent experiments.
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Table 4 – Cell cycle distribution for NCI-H460 human
lung cancer cells treated with herbal extracts comprising
EE-KKBS
% Cells on each cell cycle phase at 24
h treatment
G0/G1 G2/M S
Control 55.25 ± 3.72 15.77 ± 3.28 28.98 ± 0.45
EE-KKBS 82.63 ± 0.59 6.54 ± 1.37 10.83 ± 0.79
EE-CT 79.77 ± 1.85 6.25 ± 1.49 14.04 ± 0.45Data are presented as the mean ± standard deviation for three indep
EE-KKBS, ethanol extract of Kilkyung-baeksan.
s cell cycle arrest. To test this possibility, cell cycle proﬁle
hanges after EE-KKBS treatment were assessed in human
ung cancer cell lines. As demonstrated in Fig. 2A and Table 3,
E-KKBS treated NCI-H460 cells showed strong G0/G1 arrest
n cell cycle proﬁles compared with nontreated control cells.
he percentage of cells in G0/G1 phase increased from 58.31%
o 83.99%, 55.25% to 82.63%, and 69.43% to 91.24% at 16hours,
4hours, and 48hours after 100microgram/mL EE-KKBS treat-
ent, respectively (Table 3). At the same time point, there was
igniﬁcant decrease in cells in S phase and slight decrease
n cells in G2/M phase (Fig. 2A and Table 3). Another human
ung cancer cell line, A549, also showed strong G0/G1 arrest by
E-KKBS treatment (data not shown).
ig. 1 – Effect of EE-KKBS on NCI-H460 human lung cancer
ells. NCI-H460 cells were vehicle (0.1% DMSO) or EE-KKBS
100microgram/mL) for the indicated time then collected for
easuring total cell counts and cell viabilities. (One
epresentative experiment done in triplicates). (A) Total cell
umbers after 16hours, 24hours, 48hours, and 72hours of
reatment. (B) Cell viabilities at each time point.
MSO, dimethyl sulfoxide; EE-KKBS, ethanol extract of
ilkyung-baeksan.
EE-PG 54.71 ± 0.80 20.23 ± 0.96 25.07 ± 0.16
EE-FT 53.02 ± 0.65 19.95 ± 0.94 27.04 ± 1.59
Data are presented as themean ± standard deviation for three inde-
pendent experiments.
EE-CT, ethanol extract of Croton tiglium Linné seed; EE-PG, ethanol
extract of Platycodon grandiﬂorum A.De Candolle root; EE-FT, ethanol
extract of Fritillaria thunbergii Miquel bulb; EE-KKBS, ethanol extract
of Kilkyung-baeksan.
3.3. Effect of individual herbs comprising KKBS on cell
cycle proﬁle in lung cancer cell lines
Since KKBS is a herbal formula comprised of three medici-
nal herbs, it is necessary to determine the cell cycle arrest
induced by this formula comes from one of component herbs
or the synergistic effect of multi-herbal extract. Among three
component herbs, only ethanol extract of Croton tiglium Linné
(EE-CT) showed potent G0/G1 cell cycle arrest which was com-
parable to EE-KKBS in both NCI-H460 and A549 human lung
cancer cell lines (Fig. 2B, Table 4, and data not shown).
3.4. Effect of EE-KKBS and EE-CT on cell cycle-related
protein expressions
The effects of KKBS and/or EE-CT on the expression of cell
cycle-related proteins in NCI-H460 cells were evaluated by
Western blot analysis. As presented in Fig. 3, EE-KKBS treat-
ment causedupregulation of p21 andp27 proteins inNCI-H460
cells, two key proteins in G1/S cell cycle checkpoint, resulting
in cell cycle arrest in G0/G1 phase. As expected, EE-CT treat-
ment also increased the expression of both proteins (Fig. 3).
4. DiscussionCancer has been the leading cause of death worldwide and
has become a major public health problem. Lung cancer is the
182 Integr Med Res ( 2 0 1 5 ) 178–184
Fig. 2 – Effect of EE-KKBS (A) and component herbs (B) on NCI-H460 cell cycle progression. (A) Cells were treated with either
vehicle (0.1% DMSO) or EE-KKBS (100microgram/mL) for the indicated time, stained with PI and analyzed by ﬂow cytometry.
(B) Cells were treated with either vehicle (0.1% DMSO) or each herbal extracts (100microgram/mL) for 24hours, then stained
with PI and analyzed by ﬂow cytometry.
DMSO, dimethyl sulfoxide; EE-KKBS, ethanol extract of Kilkyung-baeksan; EE-CT, ethanol extract of Croton tiglium Linne
seed; EE-PG, ethanol extract of Platycodon grandiﬂorum A.De Candolle root; EE-FT, ethanol extract of Fritillaria thunbergii
Miquel bulb; PI, propidium iodide.leading cause of cancer deaths, and in most cases, the cancer
has already spread and/or metastasized at the time of diagno-
sis, therefore only limited therapeutic options are available.
Currently platinum-based mixed chemotherapy is the stan-
dard treatment for advanced lung cancer, especially NSCLC,however, chemotherapy in patients with advanced NSCLC has
response rate of only < 35% with severe toxicity.11,12 Due to
these limits of the current treatment, herbal medicines and
phytochemicals draw a lot of attention for novel therapeutics
development since these have been used traditionally with
J. Kim et al/KKBS regulates G1 cell cycle checkpoint in lung cancer
Fig. 3 – Expressions of cell cycle checkpoint proteins in
NCI-H460 human lung cancer cell line treated with EE-KKBS
(50microgram/mL and 100microgram/mL) or EE-CT
(50microgram/mL and 100microgram/mL). Numbers below
each lane represent normalized expressions of each protein
over actin protein.
EE-CT, ethanol extract of Croton tiglium; EE-KKBS, ethanol
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ittle or no harmful effects. There are reports that suggest
sing herbal medicines and phytochemicals for lung cancer
reatment and/or prevention.13,14
KKBS has a long history of traditional use in Korea and
hina for various symptoms of respiratory diseases. In the
resent study, we found that ethanol extract of KKBS (EE-
KBS) induced a signiﬁcant growth arrest effect on various
ung cancer cell lines in a time dependent manner (Table 2
nd Fig. 1A). There was no change in the viability of EE-KKBS
reated cells, we assumed that the effect of EE-KKBS on lung
ancer cells was not cytotoxic (Fig. 1B). Furthermore, lung can-
er cell lines treated with EE-KKBS displayed strong G0/G1
rrested cell cycle proﬁles without increased sub G1 popula-
ion (Fig. 2A and Table 3) which strongly suggested cytostatic
roperty of EE-KKBS.
One of the KKBS components, Platycodon grandiﬂorum Radix
as been shown to elicit anticancer activity by inducing apo-
tosis in various cancer cell lines,6,7 however, in our study,
oneof the componentherbs comprisingKKBSexhibited cyto-
oxic effect on lung cancer cell lines. Our effort to ﬁnd the
omponent herb with cell cycle arrest property revealed that
he ethanol extract of Croton tiglium seed (EE-CT) possessed a
otent G0/G1 cell cycle arrest activity (Fig. 2B and Table 4). We
urther analyzed which solvent fraction of EE-CT contained
he substance(s) responsible for arrest of cell cycle. All sub-
ractions except water fraction showed G0/G1 arrest between
4hours and 48hours treatment, although there were differ-
nt magnitudes of cell cycle arrest (data not shown). Of these,
he ethyl acetate subfraction displayed the most potent activ-
ty in G0/G1 arrest, up to 95% of cells in G0/G1 phase from
4hours post treatment and this arrest continued to 48hours
data not shown). Interestingly, our preliminary study indi-
ated that this G0/G1 arrest effect of EE-CT and subsequent183
solvent fractions of EE-CT only limited to the cancer cells from
lung origin and failed to induce cell cycle arrest in other types
of cancer cell lines such as C33a cervical carcinoma cell or
HT1080 ﬁbrosarcoma cell lines (data not shown)
Many gene products such as p27, and p21 have been
demonstrated to play important roles in regulating cell cycle
checkpoints. Both proteins are members of the Cip/Kip fam-
ily of cyclin-dependent kinase inhibitors and act as inhibitors
of cell cycle progression. In association with CDK2 complexes,
these proteins inhibit kinase activity of CDKs and block pro-
gression through G1/S.15 To clarify the underlying molecular
mechanism of G0/G1 arrest induced by EE-KKBS and EE-CT,
the expression levels of these two proteins were examined.
Our study indicated that p21 and p27, two key modulators of
G1 checkpoint, were upregulated in lung cancer cells treated
with EE-KKBS and EE-CT (Fig. 3).
In summary, our results suggested that EE-KKBS and its
component herb, EE-CT, inhibited growth of lung cancer cells
without cytotoxic effect. This antiproliferative property of EE-
EE-KKBS was possibly mediated by enhancing the expressions
of p21 and p27 proteins, regulating G1 checkpoint of cell cycle.
Although the detailed mechanism of action, identiﬁcation of
active ingredients, and efﬁcacy conﬁrmation in animalmodels
need to be veriﬁed, our data suggest that EE-KKBS could be a
good candidate for lung cancer adjuvant therapy for regulating
uncontrolled cancer growth.
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